Discover exclusive news, ideas and insights from across the spectrum of healthcare innovation.

How will you advance healthcare?

Regular

New York Gov. Kathy Hochul tours Lab of the Future with Michael Foley, PhD, CEO of Deerfield Discovery & Development and Cure CEO Seema Kumar on Sept. 19, 2024

New York State Governor Kathy Hochul

New York Gov. Hochul Tours Lab of the Future at Cure

Increased Eastern equine encephalitis (EEE) cases in 2024, likely influenced by warmer weather, has led to public health warnings and actions.

Encephalitis vaccines thumbnail 1200x675

Eastern Equine Encephalitis: Tackling a Rare but Severe Disease

Lexeo Therapeutics is developing pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease.

Lexeo Therapeutics: Revolutionizing Genetic Medicine for Cardiovascular and Neurodegenerative Diseases 

As the flu season approaches and COVID-19 remains a significant concern, understanding the optimal timing for vaccinations is crucial.

vaccinations timing thumbnail 1200x675

It’s That Time Again: The Importance of Timing for Flu and COVID-19 Vaccinations 

General David H. Petraeus discussed the challenges to healthcare posed by global conflicts at the C3 Healthcare Summit, aka "Davos of Healthcare."


Healthcare Delivery and Innovation in a World of Conflict 

Neuropharmacology and drug deliver expert Ashiwel Undieh, PhD, shares how his 2021 XSeed Award accelerated and enables his research. 

thumbnail-ashiwel-undieh

One Unrestricted Grant Yields Multiple Opportunities for Health

Alex Zhavoronkov, PhD, CEO of Insilico Medicine, presents the keynote at the #GenAI4Pharma at Cure.

thumbnail-alex-zhavoronkov-genai4pharma

Alex Zhavoronkov, PhD, CEO of Insilico Medicine, to Address #GenAI4Pharma Showcase at Cure

Shwen Gwee, digital health and corporate innovator, created #GenAI4Pharma to help biopharma adopt generative AI and LLM-related tech for every life stage of new therapies.

thumbnail-genai4pharma-article

6 Things to Know about #GenAI4Pharma

Operators of senior living facilities face several challenges that could hamper their ability to recruit and retain residents. They need to 
embrace everything from new hiring and staff training to technology advances using AI. 

thumbnail-white-paper-senior-living-ver02

thumbnail-white-paper-senior-living

Competition, Labor and Costs Challenge High Growth of Senior Living Market 

thumbnail-fast-facts-about-us-residential-care-communities

Fast Facts about the 1M+ in US Residential Care Communities

Teams led by Carol M. Troy, MD, PhD, of Columbia University Medical Center, and Paraskevi Giannakakou, PhD, of Weill Cornell Medical College, each received $250,000 grants as winners of the fourth annual XSeed Award.

thumbnail-xseed2024-winners-carol-evie

Troy, Giannakakou Named 2024 XSeed Award Winners

3DC drug discovery scientist Christine Brideau's translational science expertise helps advance basic research to clinical studies to successful medicines. She also helps pick XSeed Award winners developing their own new drugs. 

Insights_Article_Spotlight on Christine Brideau, Drug Discovery Scientist and XSeed Award Judge

Spotlight on Christine Brideau, Drug Discovery Scientist and XSeed Award Judge

For more than three decades, Laura Esserman, MD, has pushed aggressively to change the treatment paradigm for patients with breast cancer, believing that medicine can do more to personalize care.

thumbnail-laura-esserman-profile

Laura Esserman, MD: A Force for Changing the Breast Cancer Treatment Paradigm 

thumbnail-nalw2024-thumbnail

5 Things to Know about National Assisted Living Week, Sept. 8 to 14

Nigerian-born Chidiebere Awah, MD, PhD, CEO of UTR Therapeutics Inc., has created a technology with potential to not only take on aggressive cancers, but also Alzheimer’s disease, metabolic diseases and more.

Chidiebere Uzodinma Awah, MD, PhD, CEO of UTR Therapeutics Inc.

How Funding and Mentorship Forged a New Path to Fight Cancer

Life Science Sherpas helps venture-backed companies create connections and foster deals via networking. 

Life Science Sherpas

Life Science Sherpas Fosters Connections and Deal-Making

Life science startups may be cash-strapped, but stock-based awards may be just the ticket to create competitive employee compensation packages.

thumbnail-equity-article

5 Equity Awards Life Science Startups Use to Incentivize Talent

Dori Thomas-Karyat, PhD, is developing a potential first-in-class treatment for idiopathic pulmonary fibrosis — a progressive debilitating lung disease with limited therapeutic options.

XSeed Past Winner Dori Thomas Karyat 

Spotlight on XSeed Award Finalist: Dori Thomas-Karyat, PhD, Founder and CEO of Synthis Therapeutics 

Understanding how life sciences entrepreneurs can best use patents and copyrights to safeguard IP as an asset offers protection against others copying the discovery and can help set up a smoother path to market.
 

thumbnail-intellectual-property-article

The Ins and Outs of Intellectual Property in Life Sciences

Jahanara Ali, PhD, of NomoCan Pharmaceuticals, is developing a first-in-class monoclonal antibody to treat patients with the blood cancer acute myeloid leukemia (AML), but it may have applications for solid tumor cancers.

thumbnail-xseed-2024-jahanara-ali

Spotlight on XSeed Award Finalist: Jahanara Ali, PhD, Chief Business Officer, NomoCan Pharmaceuticals

Liquid biopsy developers will need to overcome test accuracy and reimbursement hurdles to meet market projections.

cure-hp-carousel-liquid-biopsys-white-paper

cure_hp_carousel_liquid-biopsy-white-paper

Hopes and Hurdles for Liquid Biopsy Technology

Melissa Wallace launched Fierce Foundry in 2023 to build companies that not only improve the lives of women, but create a new investment flywheel for female founders.

thumbnail-tuesday-talks-fierce-foundry-melissa-wallace

Fierce Foundry’s Innovative Approach to Funding and Accelerating FemTech

Paraskevi Giannakakou, PhD, is developing a first-in-class small molecule that may defeat the resistance many patients with advanced prostate cancer develop to standard-of-care anticancer drugs.

thumbnail-xseed-2024-evi-giannakakou

Spotlight on XSeed Award Finalist: Paraskevi Giannakakou, PhD, Co-Founder, ARMA BIO

Carolee Lee founded Women's Health Access Matters to accelerate funding for women’s health research, which benefits the economy.

thumbnail-article-carolee-lee-breaking-barriers

Carolee Lee on Why Increasing Women's Access to Healthcare Can Boost the Economy for All of Us

The U.S. government's ARPA-H launched HEROS to make preventing illness as rewarding as delivery acute care for providers, creating more equitable, health outcomes for all Americans.

thumbnail-arpah-heroes-program-preventive

ARPA-H's HEROES Program Accelerates Preventive Health Innovations

XSeed Award Finalist Daria Lizneva, MD, PhD, is developing a potential first-in-class small molecule for the long-term management of obesity.

thumbnail-daria-lizneva-xseed-war-winner-2024

Spotlight on XSeed Award Finalist: Daria Lizneva, MD, PhD, Mount Sinai

Oben Health is improving care access using AI to facilitate screenings, education and connections to treatment in nontraditional spaces like barbershops, havens of support especially in communities of color.



thumbnail-oben-health-barbershop-model

Delivering Healthcare in Places of Trust: The Oben Health Barbershop Model

Elemento leads efforts to tailor treatments for individual patients’ diseases by deciphering their molecular roots with cutting-edge technologies.

thumbnail_olivier_elemento

Olivier Elemento’s Vision for Mainstreaming Precision Medicine

XSeed Award Finalist Carol M. Troy, MD, PhD, is developing a novel eye drop medication that could become the first noninvasive treatment for retinal vascular occlusion.

4th Annual XSeed Awards Carol Troy

Spotlight on XSeed Award Finalist:  Carol Troy, MD, PhD, Columbia University Neurologist 

Most biomedical researchers agree that the promise of AI for the future drug discovery is likely to be extraordinary. What can we expect in the  next decade?

thumbnail_five_ways_AI_influence_drug_discovery

Five Ways AI May Influence the Future of Drug Discovery

thumbnail_white_paper_non-invasive_prenatal_testing_ver02

Consensus and Controversy: Clinicians’ Views of Non-Invasive Prenatal Testing 

Matthew Feeley, JD, MA, a DOJ Deputy Chief and Healthcare Fraud Coordinator, recommends five steps healthcare entrepreneurs can help protect their companies.

thumbnail_tuesday_talks_matthew_feeley

Keeping It Legal: Five Tips for Entrepreneurs from Department of Justice Attorney

Emily Heikamp, MD, PhD, a physician-scientist at Harvard and Dana-Farber, is making strides in better understanding what drives acute myeloid leukemia, with a focus on fusion proteins as potential targets to thwart the cancer.

Emily Heikamp AML Summit

Heikamp Honored for Work Targeting Fusion Proteins to Thwart AML 

Leveraging her background ​as a food scientist, ​Laura Katz, MA, ​founded​ and helms Helaina, a company using its​ proprietary precision ​​fermentation platform to recreate the ​bioactive proteins found in​ human colostrum and​ milk​ to improve health for people of all ages​. 

Events Thumbnail Tuesday Talks Laura Katz 

Helaina: Transforming Nutrition with Bioactive Proteins  

Joe Shonkwiler, MD, MBA, COO of ARPA-H, explains how the agency is accelerating better health outcomes for everyone by supporting development of high-impact solutions to society's most challenging health problems.



Tuesday Talks Joe Shonkwiler

ARPA-H: Funding World-Changing Ideas in Healthcare

Longevity drugs to head off diseases of aging and extend healthy lifespans are tantalizingly close, yet translating basic science discoveries to drugs still have hurdles to pass. James Peyer, PhD, CEO and Founder of Cambrian Bio talks about pursuing treatments that extend human healthspans.

thumbnail_cambrian_Bios_Drug_Strategy_age-related

Cambrian Bio’s Drug Strategy for Age-Related Diseases

Eyal Zimlichman, MD, founder of the ARC Innovation Center at Sheba Medical Center, the Middle East’s largest healthcare system, brings players in digital medicine together with external partners to accelerate change in healthcare on a global scale.

Insight Article Eyal Zimlichman Thumbnail July 2024

Sheba ARC’s Eyal Zimlichman Driving Systemic Change in Healthcare 

In the world of drug discovery, AI engenders feelings of hope, excitement and optimism. Indeed, machine learning algorithms already accelerate discovery, improve efficiency, reduce costs and even save lives.

NYAS

Inspiring Hope, Not Fear:  How AI is Already Transforming Drug Discovery

The FDA has released long-anticipated guidelines to improve diversity in clinical trials, and some biopharma experts say it's a much-needed impetus to include volunteers largely excluded from studies in the past.

thumbnail_FDA_clinical_trials_guidelines

FDA Guidance Takes Major Step Forward in Increasing Diversity in Clinical Trials

thumbnail article tuesday talks maternal mortality

Five Causes of Maternal Mortality That May Surprise You

The nonprofit Mentoring in Medicine recognizes that brilliance is everywhere, but opportunity isn’t, so it inspires and equips students from elementary to professional schools to become health care professionals through academic enrichment, leadership development, civic engagement and mentoring.

thumbnail mentoring in science

Changing Lives with Mentoring in Medicine

The startup Evvy is advancing the science of the vaginal microbiome to yield more precise diagnostics that could improve women’s health and shaping a market that has significant potential.

thumbnail How the Vaginal Microbiome May Improve Womens Healthcare

Thumbnail How the Vaginal Microbiome May Improve Women's Healthcare

Can Understanding the Vaginal Microbiome Improve Women's Health?

Thumbnail heath Ingram Blue Background

OUTbio Activists and Allies in Fight Against HIV

thumbnail 8 Steps to Create Your Startups Board

Thumbnail 8 Steps to Create Your Startup's Board

8 Boardroom Basics for New Companies

thumbnail Staffing Your Startup - 9 Considerations

Thumbnail Staffing Your Startup: 9 Considerations

Hiring 101: Staffing Your Startup

thumbnail_menopause_treatment

The $600 Billion Menopause Market

Explore the candid opinions of endocrinologists on GLP-1 drugs like Ozempic and Mounjaro. Uncover their thoughts on efficacy, patient satisfaction and the future landscape of these groundbreaking treatments in our white paper.

White Paper GLP-1

What Doctors Really Think of GLP-1 Medications

Heart Valve

Joshua Makower on How to Tackle the Medical Device Industry — and Win 

Business discussion

The Science of Leadership: 5 Insights from Evommune CEO Luis Peña

Adenovirus gene therapy liposome, illustration

Biotech’s Next Frontier

Esther Dyson

Dyson's Wellville Makes Long Term Investment in Wellbeing

A pioneer in biotechnology and prolific author, William Haseltine, PhD, has achievements including sequencing the human genome, milestone work in cancer, HIV/AIDS, genomics and COVID-19, founding more than a dozen biotech companies and reducing health disparities. He recently shared pearls of knowledge for those in biotech.

Bill_Haseltine_headshot_article_background

Haseltine's Five Take-Home Messages for Biotechnology Success

Pipetting

A Toolkit for Streamlining Biotech Clinical Trials

Female CEO

Global Perspective: Top 3 Leadership Lessons from Lexeo CEO Nolan Townsend

Sickle Cells

The Promises and Perils of Gene Editing for Sickle Cell

sascha_haubner_headshot_article_background

Leveraging CAR T Therapy to Tackle Acute Myeloid Leukemia

Biotech stakeholders aren’t just excited about the current state of biotech — they are already betting on its future prospects. Cure's Ready, Set, Growth! Biotech Benchmark Report 2024 survey asked why.

image_VR_headset_disruption_technology

Biotech Predictions for 2024 and Beyond

#moonshot conveys a seeming impossible challenge that requires disruptive, innovative thinking and the right mix of resources, talent and effort. Cure asked four healthcare thought leaders recently about their moonshots and what drives them to pursue these goals.


image_moonshot

What's Your Health Moonshot?

image women health menopause

Menopause Treatment: Delay and Disappointment

All In Her Head

It’s Not All in Her Head: Breast Cancer Surgeon Elizabeth Comen on Getting Real at Last About Women’s Health

Mature business woman mentoring

Five Steps to Improve Attention to Women's Health in the Workplace

image top-view-hand-holding-pregnancy-test

3 Reasons Employers Should Offer Fertility Benefits — from Retraining Talent to Supporting DEI Initiatives

image_womens_health_funding_investment_biotech

Igniting Innovation in Women’s Health

The overall biotech market is looking up, but in the ever-changing healthcare landscape, some areas are always hotter than others. At the height of the pandemic, for example, digital health and telehealth became booming industries. But now there are new players in town, reports Cure's Ready, Set, Growth! Biotech Benchmark Report 2024 survey. 

Pharma molecules biotech

The New Players in Town

DNA Profile

3 Changes Genomics Microscopes Bring to Understanding Disease

Isolated RNA

Overriding the Cellular Code with mRNA to Fight Cancer

Robert Pearl, MD, on the Potential for AI to Revolutionize Healthcare

Computer Screens with DNA

From Clinic to Climate: Insilico’s Alex Zhavoronkov Talks AI

Employers might not think that fertility benefits make a big difference in where employees choose to work — but they should think again. It turns out that whether or not a company has comprehensive fertility benefits is a huge draw.

Only 6 in 10 Benefit Managers Offer Fertility Benefits

From Academia to Startup CEO: Four Tips on Taking the Leap -- 324356487

From Academia to Startup CEO: Four Tips on Taking the Leap 

Life Sciences Cares

Life Science Cares Brings Biotechs Together to Aid Communities

ALS Woman in Wheelchair -- AS 518531569

What’s in a ‘Cure’ for ALS? 

Jeremy Abbate

Scientific American Publisher Shares How Reporting Must Evolve

Industrial Molecular Revolution

What is the Molecular Industrial Revolution?

Your Baby's Genome: The Radical Promise of Early DNA Testing AS383185424

A Harvard Medical School Expert on Why We Should Sequence All Babies’ Genomes

Laurie Glimcher

What Needs to Happen to Accelerate Cancer Research and Improve Care?

What's new

Blue

Explore the latest insights in healthcare innovation, featuring articles on cutting-edge research, trends, and success stories from industry leaders.

Be part of Cure.

All floors are lab-ready and cabled for digital health.

A place to Succeed.

Where scientists, entrepreneurs and visionaries converge.

Cure Events.

Critical Discussions Advancing Healthcare

Cure Tuesday Talks

Tuesday Talks

Connect with Opportunity.

Two awards up to $250,000

In-depth Insights.

A Bionic Pancreas that will Help Parents Sleep More Peacefully

How will you advance healthcare?

What's new

Featured

New York Gov. Hochul Tours Lab of the Future at Cure

Cure's White Papers

Featured

Competition, Labor and Costs Challenge High Growth of Senior Living Market

Now showing

Tuesday Talks: Navigating the Entrepreneurial Ecosystem

Streaming now

Be part of Cure.

All floors are lab-ready and cabled for digital health.

A place to Succeed.

Where scientists, entrepreneurs and visionaries converge.

Cure Events.

Critical Discussions Advancing Healthcare

Cure Tuesday Talks

Tuesday Talks

Connect with Opportunity.

Two awards up to $250,000

In-depth Insights.

A Bionic Pancreas that will Help Parents Sleep More Peacefully

How will you advance healthcare?

What's new

Featured

New York Gov. Hochul Tours Lab of the Future at Cure

Cure's White Papers

Featured

Competition, Labor and Costs Challenge High Growth of Senior Living Market

Now showing

Tuesday Talks: Navigating the Entrepreneurial Ecosystem

Streaming now

Cure Events.

Cure Tuesday Talks

In-depth Insights.